Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00403) | |||||
---|---|---|---|---|---|
Name |
Metaproterenol
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
metaproterenol; ORCIPRENALINE; 586-06-1; Alupent; Orciprenalinum; Orciprenalinum [INN-Latin]; Orciprenalina [INN-Spanish]; Prometa; Orciprenaline [INN]; 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol; Orciprenaline (INN); CHEMBL776; CHEBI:6792; 5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol; Orciprenalina; CCRIS 9017; TH-152; SR-01000075168; EINECS 209-569-1; Orciprenaline [INN:BAN]; BRN 2807247; Orciprenalin; (RS)-1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol; 3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol; Spectrum_000925; ACMC-20m2sn; Prestwick0_000505; Prestwick1_000505; Prestwick2_000505; Prestwick3_000505; Spectrum2_000096; Spectrum3_000492; Spectrum4_000044; Spectrum5_000952; SCHEMBL4270; Lopac0_000734; BSPBio_000429; BSPBio_001983; KBioGR_000507; KBioSS_001405; DivK1c_000645; SPECTRUM1500390; SPBio_000052; SPBio_002350; BPBio1_000473; GTPL7250; DTXSID8048529; CHEBI:83329; HMS502A07; HY-B1276A; KBio1_000645; KBio2_001405; KBio2_003973; KBio2_006541; KBio3_001483; NINDS_000645; HMS1920L09; HMS2091D04; HMS3259J13; Pharmakon1600-01500390; 1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-; Benzyl alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-; BDBM50295572; CCG-38914; NSC757089; DB00816; MCULE-8722254342; NC00651; NSC-757089; SDCCGSBI-0050712.P005; IDI1_000645; NCGC00015655-02; NCGC00015655-03; NCGC00015655-04; NCGC00015655-05; NCGC00015655-06; NCGC00015655-14; NCGC00094718-01; NCGC00094718-02; NCGC00094718-03; SBI-0050712.P004; AB00052037; CS-0013668; C07144; D08300; 1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol; AB00052037_09; AB00052037_10; 586O061; L000678; Q416473; SR-01000075168-1; SR-01000075168-4; BRD-A07780951-001-06-3; 5-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol; 5-(1-Hydroxy-2-isopropylamino-ethyl)-benzene-1,3-diol; 3,5-dihydroxy-alpha-[(isopropylamino)methyl]benzenemethanol; 5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol; 5-[1-Hydroxy-2-(isopropylamino)ethyl]-1,3-benzenediol #; [2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium; 3,5-Dihydroxy-.alpha.-((isopropylamino)methyl)benzyl alcohol; 5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol, 6; Benzyl alcohol, 3,5-dihydroxy-.alpha.-((isopropylamino)methyl)-; 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI); 1,3-Benzenediol, 5-[(1R)-1-hydroxy-2-[(1-methylethyl)amino]ethyl]-; [2-(3,5-Dihydroxy-phenyl)-2-hydroxy-ethyl]-isopropyl-ammonium (orciprenaline); 99396-41-5
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Asthma | ICD-11: CA23 | [1] | ||
PubChem CID | |||||
Formula |
C11H17NO3
|
||||
Canonical SMILES |
CC(C)NCC(C1=CC(=CC(=C1)O)O)O
|
||||
InChI |
1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3
|
||||
InChIKey |
LMOINURANNBYCM-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4086"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 211.26 | Topological Polar Surface Area | 72.7 | |
XlogP | 0.7 | Complexity | 177 | ||
Heavy Atom Count | 15 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Metaproterenol 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Metaproterenol 20 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.